Denmark· DK-28105970117
Biktarvy
A emtricitabine, tenofovir alafenamide and bictegravir product containing bictegravirnatrium, emtricitabin, tenofovir alafenamid, registered in Denmark by Gilead Sciences Ireland UC. The same ATC class is registered in 13 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Emtricitabine, tenofovir alafenamide and bictegravir is registered in 13 of 19 countries.
Countries holding a registration under ATC J05AR20 (emtricitabine, tenofovir alafenamide and bictegravir), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Emtricitabine, tenofovir alafenamide and bictegravir · ATC J05AR20
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Bictegravirnatrium, EMTRICITABIN, tenofovir alafenamid
- Manufacturer
- Gilead Sciences Ireland UC
- Country
- Denmark (DK)
- ATC code
- J05AR20
- ATC class
- Emtricitabine, tenofovir alafenamide and bictegravir
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28105970117
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J05AR20
Emtricitabine, tenofovir alafenamide and bictegravir, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ae82cea0-2cc1-446e-86d3-fa7025e85aeb GET /v1/drugs/ae82cea0-2cc1-446e-86d3-fa7025e85aeb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "filmovertrukne tabletter",
"source": "dkma",
"strength": "50/200/25 mg",
"auth_role": "MOD",
"dk_drugid": "28105970117",
"substance": "Bictegravirnatrium, EMTRICITABIN, tenofovir alafenamid",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "43272"
}See everything about emtricitabine, tenofovir alafenamide and bictegravir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.